Source: Clinical Infectious Diseases. Unidade: FM
Subjects: PARACOCCIDIOIDOMICOSE (TERAPIA), ANTIPARASITÁRIOS (USO TERAPÊUTICO;ADMINISTRAÇÃO E DOSAGEM)
ABNT
QUEIROZ-TELLES, Flavio et al. An Open-Label Comparative Pilot Study of Oral Voriconazole and Itraconazole for Long-Term Treatment of Paracoccidioidomycosis. Clinical Infectious Diseases, v. 45, n. 11, p. 1462-1469, 2007Tradução . . Disponível em: https://doi.org/10.1086/522973. Acesso em: 18 out. 2024.APA
Queiroz-Telles, F., Goldani, L. Z., Schlamm, H. T., Goodrich, J. M., Espinel-Ingroff, A., & Shikanai-Yasud, M. A. (2007). An Open-Label Comparative Pilot Study of Oral Voriconazole and Itraconazole for Long-Term Treatment of Paracoccidioidomycosis. Clinical Infectious Diseases, 45( 11), 1462-1469. doi:10.1086/522973NLM
Queiroz-Telles F, Goldani LZ, Schlamm HT, Goodrich JM, Espinel-Ingroff A, Shikanai-Yasud MA. An Open-Label Comparative Pilot Study of Oral Voriconazole and Itraconazole for Long-Term Treatment of Paracoccidioidomycosis [Internet]. Clinical Infectious Diseases. 2007 ; 45( 11): 1462-1469.[citado 2024 out. 18 ] Available from: https://doi.org/10.1086/522973Vancouver
Queiroz-Telles F, Goldani LZ, Schlamm HT, Goodrich JM, Espinel-Ingroff A, Shikanai-Yasud MA. An Open-Label Comparative Pilot Study of Oral Voriconazole and Itraconazole for Long-Term Treatment of Paracoccidioidomycosis [Internet]. Clinical Infectious Diseases. 2007 ; 45( 11): 1462-1469.[citado 2024 out. 18 ] Available from: https://doi.org/10.1086/522973